216 related articles for article (PubMed ID: 33057566)
1. Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases.
Eitz KA; Lo SS; Soliman H; Sahgal A; Theriault A; Pinkham MB; Foote MC; Song AJ; Shi W; Redmond KJ; Gui C; Kumar AMS; Machtay M; Meyer B; Combs SE
JAMA Oncol; 2020 Dec; 6(12):1901-1909. PubMed ID: 33057566
[TBL] [Abstract][Full Text] [Related]
2. Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain Metastases.
Soliman H; Myrehaug S; Tseng CL; Ruschin M; Hashmi A; Mainprize T; Spears J; Das S; Yang V; da Costa L; Maralani P; Heyn C; Atenafu EG; Sahgal A
Neurosurgery; 2019 Nov; 85(5):E860-E869. PubMed ID: 31173150
[TBL] [Abstract][Full Text] [Related]
3. Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED
Kumar AMS; Miller J; Hoffer SA; Mansur DB; Coffey M; Lo SS; Sloan AE; Machtay M
J Neurooncol; 2018 Sep; 139(2):449-454. PubMed ID: 29749569
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Progression and Toxic Effects After Preoperative Stereotactic Radiosurgery for Patients With Resected Brain Metastases.
Prabhu RS; Akinyelu T; Vaslow ZK; Matsui JK; Haghighi N; Dan T; Mishra MV; Murphy ES; Boyles S; Perlow HK; Palmer JD; Udovicich C; Patel TR; Wardak Z; Woodworth GF; Ksendzovsky A; Yang K; Chao ST; Asher AL; Burri SH
JAMA Oncol; 2023 Aug; 9(8):1066-1073. PubMed ID: 37289451
[TBL] [Abstract][Full Text] [Related]
5. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
6. Outcomes Following Hypofractionated Stereotactic Radiotherapy to the Cavity After Surgery for Melanoma Brain Metastases.
Gallo J; Garimall S; Shanker M; Castelli J; Watkins T; Olson S; Huo M; Foote MC; Pinkham MB
Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):179-186. PubMed ID: 34642065
[TBL] [Abstract][Full Text] [Related]
7. Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases.
Garimall S; Shanker M; Johns E; Watkins T; Olson S; Huo M; Foote MC; Pinkham MB
J Neurooncol; 2020 Jan; 146(2):357-362. PubMed ID: 31907796
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer : Evaluation of indications and predictors of local control.
Ishihara T; Yamada K; Harada A; Isogai K; Tonosaki Y; Demizu Y; Miyawaki D; Yoshida K; Ejima Y; Sasaki R
Strahlenther Onkol; 2016 Jun; 192(6):386-93. PubMed ID: 27169391
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases.
Kwon AK; Dibiase SJ; Wang B; Hughes SL; Milcarek B; Zhu Y
Cancer; 2009 Feb; 115(4):890-8. PubMed ID: 19132728
[TBL] [Abstract][Full Text] [Related]
11. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated postoperative stereotactic radiotherapy for large resected brain metastases.
Evin C; Eude Y; Jacob J; Jenny C; Bourdais R; Mathon B; Valery CA; Clausse E; Simon JM; Maingon P; Feuvret L
Cancer Radiother; 2023 Apr; 27(2):87-95. PubMed ID: 36075831
[TBL] [Abstract][Full Text] [Related]
13. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters.
Jiang XS; Xiao JP; Zhang Y; Xu YJ; Li XP; Chen XJ; Huang XD; Yi JL; Gao L; Li YX
Radiat Oncol; 2012 Mar; 7():36. PubMed ID: 22429918
[TBL] [Abstract][Full Text] [Related]
15. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
16. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial.
Churilla TM; Chowdhury IH; Handorf E; Collette L; Collette S; Dong Y; Alexander BM; Kocher M; Soffietti R; Claus EB; Weiss SE
JAMA Oncol; 2019 Feb; 5(2):243-247. PubMed ID: 30419088
[TBL] [Abstract][Full Text] [Related]
18. Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.
Wernicke AG; Yondorf MZ; Peng L; Trichter S; Nedialkova L; Sabbas A; Kulidzhanov F; Parashar B; Nori D; Clifford Chao KS; Christos P; Kovanlikaya I; Pannullo S; Boockvar JA; Stieg PE; Schwartz TH
J Neurosurg; 2014 Aug; 121(2):338-48. PubMed ID: 24785322
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation.
Eaton BR; Gebhardt B; Prabhu R; Shu HK; Curran WJ; Crocker I
Radiat Oncol; 2013 Jun; 8():135. PubMed ID: 23759065
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
